Nathan Averill, MD
Family Medicine · Moncks Corner, SCNPI 1891824355
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $16,392 of the $25,451 with a category attached, or 64.4%. 60 manufacturers reported payments, led by AbbVie at 46.9% of the total. Reporting peaked in 2024 at $7,174 and has fallen 59.3% since, to $2,919 in 2025. Among family medicine clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,012 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- Novo Nordisk$1K
- AstraZeneca$1K
- Lilly USA, LLC$1K
- GSK$950
- Pfizer$791
- plus $8K from 54 others
What the payments were for
- Speaking & faculty fees$9,00035%
- Food & beverage$16,39264%
- Education$590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,451 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 166 | $251,536 |
| EliquisApixaban | 95 | $114,722 |
| MounjaroTirzepatide | 57 | $85,219 |
| TrulicityDulaglutide | 45 | $70,277 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 67 | $67,090 |
| JardianceEmpagliflozin | 42 | $53,951 |
| EntrestoSacubitril/Valsartan | 43 | $49,938 |
| VraylarCariprazine Hcl | 25 | $40,013 |
| XareltoRivaroxaban | 33 | $39,695 |
| FarxigaDapagliflozin Propanediol | 25 | $29,638 |
| LinzessLinaclotide | 22 | $25,130 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 16 | $11,078 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $9,411 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,477 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 39 | $6,461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,226 | $251,536166 claims |
| Lilly USA, LLCMounjaro, Trulicity | $1,136 | $155,496102 claims |
| PfizerEliquis | $791 | $114,72295 claims |
| GSKTrelegy Ellipta | $950 | $67,09067 claims |
| AbbVieVraylar, Linzess, Synthroid | $11,929 | $66,76578 claims |
| Boehringer IngelheimJardiance | $176 | $53,95142 claims |
| NovartisEntresto | $455 | $49,93843 claims |
| Johnson & JohnsonXarelto | $288 | $39,69533 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,213 | $37,11537 claims |
| MerckJanumet Xr, Januvia | $168 | $17,02827 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $63 | $2,001251 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Moncks Corner
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.